Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

An Institutional Retrospective Study on Recognizing the Delay in Multiple Myeloma Diagnosis

Nima Ghalehsari, MD, Pragnan Kancharla, MD MBBS, Neil S Nimkar, MD, Anita Mazloom, MD, Farah Ashraf, DO, Angelica Singh, MD, Mendel Goldfinger, MD

Blood (2019) 134 (Supplement_1): 3430.

https://doi.org/10.1182/blood-2019-127625

Published: 2019

Journal Articles

Retrospective Study of Patients with Upper Extremity Clots Presenting to Emergency Departments in Tertiary Care Hospitals in a Major Canadian City in the Last Five Years

Tania Pannu, MD, Eric Herget, MD, Deepa Suryanarayan, MBBS

Blood (2019) 134 (Supplement_1): 1163.

https://doi.org/10.1182/blood-2019-131497

Published: 2019

Journal Articles

Management Strategies and Satisfaction Levels in Patients with Sickle Cell Disease: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)

John James, MSc, Biree Andemariam, MD, Baba PD Inusa, MD, Fuad El-Rassi, Beverly Francis-Gibson, Alecia C. Nero, MD, Caterina P. Minniti, MD, Cassandra Trimnell, BA, Miguel R. Abboud, MD, Jean-Benoît Arlet, Raffaella Colombatti, Mariane de Montalembert, MD PhD, Suman Jain, Wasil Jastaniah, Erfan Nur, MD PhD, Laurie DeBonnett, MD, Ifeyinwa (ify) Osunkwo, MD MPH

Blood (2019) 134 (Supplement_1): 1017.

https://doi.org/10.1182/blood-2019-123643

Published: 2019

Journal Articles

Pulmonary Embolism Home Treatment: What GP Want?

Clemence Calais, MD, Gregoire Mercier, MD PhD, Arthur Meusy, MD, Isabelle Quere, MD PhD, Jean-Philippe Galanaud, MD PhD

Blood (2019) 134 (Supplement_1): 4699.

https://doi.org/10.1182/blood-2019-122053

Published: 2019

Journal Articles

Greatalys: Generating Real World Evidence across Italy in Sickle Cell Disease

Chiara Castiglioni, Claudia Condorelli, Paola Amore, Valentina Perrone, Davide Alessandrini, Chiara Veronesi, Luca Degli Esposti, Eleonora Premoli, Carina Fiocchi

Blood (2019) 134 (Supplement_1): 4707.

https://doi.org/10.1182/blood-2019-125612

Published: 2019

Journal Articles

GECAT - German Evaluation of Cancer Associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism (VTE) in Berlin

Marianne Sinn, Christiane Pollich, Hanno Riess, Sven Bischoff, Piet Habbel, Christian W Scholz, Ernst Spaeth-Schwalbe, Maike de Wit, Anja Jühling, Eike Wolter, Lilianna Wislocka, Dr. Klamroth

Blood (2019) 134 (Supplement_1): 4969.

https://doi.org/10.1182/blood-2019-128166

Published: 2019

Journal Articles

Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Romain Buono, Solene Poirey, Isabela Pascu, Emmanuelle Nicolas-Virelizier, MD, Souad Assaad, MD, Amine Belhabri, Laure Lebras, MD, Yann Guillermin, MD, Philippe Rey, MD, Lila Gilis, MD, Franck E Nicolini, MD PhD, Stephane Morisset, BioStat, Audrey Couillet, Gisele Chvetzoff, Jean-Yves Blay, MD PhD, Beatrice Fervers, Anne-Sophie Michallet, MD PhD

Blood (2019) 134 (Supplement_1): 5817.

https://doi.org/10.1182/blood-2019-130597

Published: 2019

Journal Articles

Level of Utilization and Provider-Related Barriers to Hydroxyurea Use in the Treatment of Sickle Cell Disease in Jos, Nigeria

Akinyemi Olugbenga David Ofakunrin, MBBS, Kehinde Adekola, MD MS, Edache Sylvanus Okpe, MBBS, FWACP, Stephen Oguche, MBBS, FMCPaed, Tolulope Afolaranmi, MBBS, FWACP, Patience Kanhu, MBBS, FMCPaed, Nantok Dami, MBBS, Atiene Solomon Sagay, MBBS, FMCOG, FRCOG

Blood (2019) 134 (Supplement_1): 1029.

https://doi.org/10.1182/blood-2019-128185

Published: 2019

Journal Articles

Hydroxyurea Therapy Does Not Impact Current Survival Estimates in the East London Sickle Cell Newborn Cohort Study

Paul Telfer, Banu Kaya, MD, Dimitris A. Tsitsikas, Filipa Barroso, MD, Cynthia Sangarappillai, BSc

Blood (2018) 132 (Supplement 1): 3655.

https://doi.org/10.1182/blood-2018-99-116544

Published: 2018

Journal Articles

Treatment Patterns and Healthcare Resource Utilization (HRU) in Patients with Relapsed/Refractory (R/R) FLT3 -Mutated ( FLT3 mut ) and FLT3 -Wild Type ( FLT3 wt ) Acute Myeloid Leukemia (AML): A Multi-Country Medical Chart Study

James D. Griffin, MD, Manasee V Shah, MPH, Yan Song, PhD, Hongbo Yang, PhD

Blood (2018) 132 (Supplement 1): 4824.

https://doi.org/10.1182/blood-2018-99-110871

Published: 2018

Journal Articles

Excellence in PNH in Canada (EPIC): A Single Centre Pilot Project Evaluating Disease Trajectory for PNH Patients Receiving Eculizumab

Michael James Vernon, MD BSc, Kevin H. M. Kuo, MD MSc, FRCPC, Rebecca Leroux, BSc, Christopher J. Patriquin, MD MSc, FRCPC

Blood (2018) 132 (Supplement 1): 4879.

https://doi.org/10.1182/blood-2018-99-112337

Published: 2018

Journal Articles

Home Care of Acute Leukemia Patients: From Active Therapy to End-of-Life and Palliative Care. a Three-Year Experience of a Single Centre

Isabella Capodanno, MD, Pierluigi Alfieri, MD, Enrica Tamagnini, nurse, Katia Codeluppi, PhD, Stefano Luminari, MD, Francesco Merli, MD

Blood (2018) 132 (Supplement 1): 5867.

https://doi.org/10.1182/blood-2018-99-118205

Published: 2018

Journal Articles

Assessing Needs for Support in MDS Patients

Esther Natalie Oliva, MD, Raqeebah Agberemi, Sophie Wintrich

Blood (2018) 132 (Supplement 1): 2313.

https://doi.org/10.1182/blood-2018-99-112967

Published: 2018

Journal Articles

Risk of Second Malignancies in Long Term Hodgkin Lymphoma Survivors of Two Age Cohorts

Nikita Kondapalli, Manini Suchita Penikalapati, Sreya Yalamanchili, Rakesh Surapaneni, MD

Blood (2017) 130 (Supplement 1): 4099.

https://doi.org/10.1182/blood.V130.Suppl_1.4099.4099

Published: 2017

Journal Articles

Diagnostic Role of Calreticulin Mutation in Patients with Ph/JAK2/MPL Negative Myeloproliferative Neoplasm Not Identified at Disease Presentation

Tanja Belcic, MD, Sasa Anzej Doma, MD PhD, Irena Zupan, MD PhD, Martina Fink, PhD, Natasa Debeljak, PhD, Tadej Pajic, Matjaz Sever, MD PhD

Blood (2017) 130 (Supplement 1): 5278.

https://doi.org/10.1182/blood.V130.Suppl_1.5278.5278

Published: 2017

Journal Articles

Prediagnostic Progression of Lymphocytosis in Chronic Lymphocytic Leukemia Is Predictive of Progression Free Survival As Early As Five Years Prior to Diagnosis

Michael Asger Andersen, MD, Mia Klinten Grand, Volkert Siersma, Niels Olivarius, Christen Lykkegaard Andersen, MD, Carsten Utoft Niemann, MD PhD

Blood (2017) 130 (Supplement 1): 1726.

https://doi.org/10.1182/blood.V130.Suppl_1.1726.1726

Published: 2017

Journal Articles

A Geriatric Screening Tool (G8) Provides an Independent Prognostic Index for Azacitidine Treated Elderly MDS Patients

Angela Molga, MBBS, FRACP, Michelle Wall, Dip HE (Nursing), BA (Hons), MSc, PG Cert, Deepak Singhal, MBBS, MD FRCPA, FRACP, Rakchha Chhetri, MBBS, Amilia Wee, BSc (Hons), Lucy Cussans, Nimit Singhal, MBBS MDDM FRACP, Gillian Caughey, PhD, Luen Bik To, MBBS, FRACP, FRCPA, PhD, Peter Bardy, MBBS, FRACP, FRCPA, FRCPath, Sepehr Shakib, MBBS, FRACP, PhD, Ian D Lewis, MBBS, PhD FRACP, FRCPA, Timothy To, BSc, BMBS, FRACP, FAChPM, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2017) 130 (Supplement 1): 1692.

https://doi.org/10.1182/blood.V130.Suppl_1.1692.1692

Published: 2017

Journal Articles

Time from First Symptom Onset to the Final Diagnosis of Multiple Myeloma — Possible Risks and Future Solutions: Large Retrospective and Confirmatory Prospective 'Deutsche Studiengruppe Multiples Myelom' (DSMM) Analysis

Giulia Graziani, Georg W. Herget, Gabriele Ihorst, Henning Schäfer, Jakob Neubauer, Annette M. May, Justus Duyster, Hermann Einsele, Ralph Wäsch, Monika Engelhardt

Blood (2017) 130 (Supplement 1): 4710.

https://doi.org/10.1182/blood.V130.Suppl_1.4710.4710

Published: 2017

Journal Articles

An Intensive Transition Navigator Intervention Improves Transition Readiness to Adult Care in Youth with Sickle Cell Disease

Deepa Manwani, MD, Lynn Davidson, MD, Ellen Silver, Rosy Chhabra, PsyD, Caterina Minniti, MD, Deepa Rastogi, MD, Maya Doyle, LCSW-R, PhD, Kerry A Morrone, MD, Ruth Stein, MD, Suzette Oyeku, MD MPH, Laurie Bauman, PhD

Blood (2017) 130 (Supplement 1): 4634.

https://doi.org/10.1182/blood.V130.Suppl_1.4634.4634

Published: 2017

Journal Articles

Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry

Christine Teutsch, Menno V Huisman, Gregory Y.H. Lip, Hans-Christoph Diener, Sergio J Dubner, Ma Changsheng, Kenneth J Rothman, Kristina Zint, Amelie Elsaesser, Miney Paquette, Dorothee B Bartels, Jonathan Halperin

Blood (2016) 128 (22): 2616.

https://doi.org/10.1182/blood.V128.22.2616.2616

Published: 2016

NARROW

An Institutional Retrospective Study on Recognizing the Delay in Multiple Myeloma Diagnosis

Retrospective Study of Patients with Upper Extremity Clots Presenting to Emergency Departments in Tertiary Care Hospitals in a Major Canadian City in the Last Five Years

Management Strategies and Satisfaction Levels in Patients with Sickle Cell Disease: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)

Pulmonary Embolism Home Treatment: What GP Want?

Greatalys: Generating Real World Evidence across Italy in Sickle Cell Disease

GECAT - German Evaluation of Cancer Associated Thrombosis: A Prospective Register Trial for Patients with Active Cancer and Venous Thromboembolism (VTE) in Berlin

Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study

Level of Utilization and Provider-Related Barriers to Hydroxyurea Use in the Treatment of Sickle Cell Disease in Jos, Nigeria

Hydroxyurea Therapy Does Not Impact Current Survival Estimates in the East London Sickle Cell Newborn Cohort Study

Treatment Patterns and Healthcare Resource Utilization (HRU) in Patients with Relapsed/Refractory (R/R) FLT3 -Mutated ( FLT3 mut ) and FLT3 -Wild Type ( FLT3 wt ) Acute Myeloid Leukemia (AML): A Multi-Country Medical Chart Study

Excellence in PNH in Canada (EPIC): A Single Centre Pilot Project Evaluating Disease Trajectory for PNH Patients Receiving Eculizumab

Home Care of Acute Leukemia Patients: From Active Therapy to End-of-Life and Palliative Care. a Three-Year Experience of a Single Centre

Assessing Needs for Support in MDS Patients

Risk of Second Malignancies in Long Term Hodgkin Lymphoma Survivors of Two Age Cohorts

Diagnostic Role of Calreticulin Mutation in Patients with Ph/JAK2/MPL Negative Myeloproliferative Neoplasm Not Identified at Disease Presentation

Prediagnostic Progression of Lymphocytosis in Chronic Lymphocytic Leukemia Is Predictive of Progression Free Survival As Early As Five Years Prior to Diagnosis

A Geriatric Screening Tool (G8) Provides an Independent Prognostic Index for Azacitidine Treated Elderly MDS Patients

Time from First Symptom Onset to the Final Diagnosis of Multiple Myeloma — Possible Risks and Future Solutions: Large Retrospective and Confirmatory Prospective 'Deutsche Studiengruppe Multiples Myelom' (DSMM) Analysis

An Intensive Transition Navigator Intervention Improves Transition Readiness to Adult Care in Youth with Sickle Cell Disease

Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only